|
TANIAI Makiko
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Position Associate Professor |
|
| Article types | Original article |
| Language | English |
| Peer review | Peer reviewed |
| Title | Hepatocellular carcinoma after direct-acting antiviral drug treatment in patients with hepatitis C virus. |
| Journal | Formal name：JGH open : an open access journal of gastroenterology and hepatology Abbreviation：JGH Open ISSN code：(2397-9070)2397-9070(Linking) |
| Volume, Issue, Page | 3(1),pp.52-60 |
| Author and coauthor | KOGISO Tomomi, SAGAWA Takaomi, KODAMA Kazuhisa, TANIAI Makiko, KATAGIRI Satoshi, EGAWA Hiroto, YAMAMOTO Masakazu, TOKUSHIGE Katsutoshi |
| Publication date | 2019/02 |
| Summary | DAA did not increase the rate of HCC, even in immunosuppressed patients. However, careful follow-up for HCC recurrence is required in previously treated cases. |
| DOI | 10.1002/jgh3.12105 |
| PMID | 30834341 |